Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2014:2014:324307.
doi: 10.1155/2014/324307. Epub 2014 Dec 7.

Vinpocetine and pyritinol: a new model for blood rheological modulation in cerebrovascular disorders—a randomized controlled clinical study

Affiliations
Randomized Controlled Trial

Vinpocetine and pyritinol: a new model for blood rheological modulation in cerebrovascular disorders—a randomized controlled clinical study

Hayder M Alkuraishy et al. Biomed Res Int. 2014.

Abstract

Blood and plasma viscosity are the major factors affecting blood flow and normal circulation. Whole blood viscosity is mainly affected by plasma viscosity, red blood cell deformability/aggregation and hematocrit, and other physiological factors. Thirty patients (twenty males + ten females) with age range 50-65 years, normotensive with history of cerebrovascular disorders, were selected according to the American Heart Stroke Association. Blood viscosity and other rheological parameters were measured after two-day abstinence from any medications. Dual effects of vinpocetine and pyritinol exhibit significant effects on all hemorheological parameters (P < 0.05), especially on low shear whole blood viscosity (P < 0.01), but they produced insignificant effects on total serum protein and high shear whole blood viscosity (P > 0.05). Therefore, joint effects of vinpocetine and pyritinol improve blood and plasma viscosity in patients with cerebrovascular disorders.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Gender differences in RBS rigidity index (RRI) in responses to the vinpocetine and/or pyritinol.

References

    1. Salazar Vázquez B. Y., Martini J., Chávez Negrete A., Tsai A. G., Forconi S., Cabrales P., Johnson P. C., Intaglietta M. Cardiovascular benefits in moderate increases of blood and plasma viscosity surpass those associated with lowering viscosity: experimental and clinical evidence. Clinical Hemorheology and Microcirculation. 2010;44(2):75–85. doi: 10.3233/CH-2010-1261. - DOI - PubMed
    1. Salazar Vázquez B. Y., Salazar Vázquez M. A., Intaglietta M., De Faire U., Fagrell B., Cabrales P. Hematocrit and mean arterial blood pressure in pre- and postmenopause women. Vascular Health and Risk Management. 2009;5:483–488. - PMC - PubMed
    1. Salazar-Vazquez B. Y., Intaglietta M., Rodŕiguez-Moŕan M., Guerrero-Romero F. Blood pressure and hematocrit in diabetes and the role of endothelial responses in the variability of blood viscosity. Diabetes Care. 2006;29(7):1523–1528. doi: 10.2337/dc06-0323. - DOI - PubMed
    1. Loscalzo J. Oxidative stress in endothelial cell dysfunction and thrombosis. Pathophysiology of Haemostasis and Thrombosis. 2002;32(5-6):359–360. doi: 10.1159/000073600. - DOI - PubMed
    1. Cecchi E., Marcucci R., Poli D., Antonucci E., Abbate R., Gensini G. F., Prisco D., Mannini L. Hyperviscosity as a possible risk factor for cerebral ischemic complications in atrial fibrillation patients. American Journal of Cardiology. 2006;97(12):1745–1748. doi: 10.1016/j.amjcard.2006.01.034. - DOI - PubMed

Publication types

LinkOut - more resources